The Commission welcomes the agreement on the revised International Health Regulations, which was reached at the World Health Assembly in Geneva. The World Health Assembly brought together over 190 countries, including all EU Member States, who together adopted an ambitious package of amendments to the International Health Regulations, following two years of intense negotiations. By …
The European Centre for Disease Prevention and Control (ECDC), the European Chemicals Agency (ECHA), the European Environment Agency (EEA), the European Food Safety Authority (EFSA), and the European Medicines Agency (EMA) published a joint framework for action to strengthen cooperation to support the implementation of the One Health agenda in the European Union (EU). One …
Avian influenza (AI) virus continues to spread in the EU and beyond, causing high mortality in wild birds, spillover to wild and domestic mammals, and outbreaks in farms. A scientific report by the European Food Safety Authority (EFSA) and the European Centre for Disease Prevention and Control (ECDC) assesses the risk factors for a potential influenza pandemic and related …
The Accelerating Clinical Trials in the EU (ACT EU) initiative has established a multi-stakeholder platform (MSP) aimed at improving the environment for clinical trials across the European Union (EU). ACT EU is a collaboration between EMA, the Heads of Medicines Agencies (HMA) and the European Commission (EC), which seeks to transform how clinical trials are initiated, designed, and run. The Accelerating Clinical Trials in the EU (ACT EU) initiative …
EP and Council negotiators agreed on the creation of a European Health Data Space to ease access to personal health data and to boost secure sharing for the public interest. Citizens will be able to access prescriptions, imagery and lab tests electronically, also from different EU countries Aggregated health data can be shared for research …
Following last year’s rare diseases conference in Bilbao, the European Economic and Social Committee and the European Commission are joining forces to deal with rare diseases at European level. Launching a joint European initiative on rare diseases to integrate the European Reference Networks (ERNs) into national health systems while building a common front among EU …
For the first time in 40 years, the EU has revisited the limit values for occupational exposure to lead and its inorganic compounds, by reducing them fivefold. These reprotoxic substances can affect sexual function and fertility, and they may also damage the nervous system, among other things. In addition, the directive is the first-ever EU …
EMA and the Heads of Medicines Agencies (HMA) have launched two public electronic catalogues: one for real-world data (RWD) sources and one for WD studies. The catalogues help medicines regulators, researchers and pharmaceutical companies to identify the most suitable data sources to address specific research questions and support the assessment of study protocols and results. They aim to promote …
While cancer survival rates have significantly increased thanks to advances in prevention, early detection, diagnosis and treatment, the number of people with a history of cancer in the EU is growing annually and is now estimated at over 12 million. Fortunately, cancers can be detected in time thanks to screening programmes. Moreover, cancer management plays an …
HaDEA has published a set of new calls under Cluster 1 ‘Health’ of Horizon Europe. Under destination 3 “Tackling diseases and reducing disease burden” the calls address pandemic preparedness and response: HORIZON-HLTH-2024-DISEASE-08-20 – Pandemic preparedness and response: Host-pathogen interactions of infectious diseases with epidemic potential HORIZON-HLTH-2024-DISEASE-08-12 – Pandemic preparedness and response: Maintaining the European partnership for pandemic preparedness Under destination …